# BORTEZOMIB

NDC: 0409-1703
Generic name: BORTEZOMIB
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20220516

FDA application: NDA209191

## Active ingredients

- BORTEZOMIB: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-1703"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-1703
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fdf6169-699f-40eb-bda1-760253062b3c